---
title: "Dynavax Tech (DVAX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DVAX.US/norm.md"
symbol: "DVAX.US"
name: "Dynavax Tech"
parent: "https://longbridge.com/en/quote/DVAX.US.md"
datetime: "2026-03-14T08:50:44.876Z"
locales:
  - [en](https://longbridge.com/en/quote/DVAX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DVAX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DVAX.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/DVAX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/DVAX.US/norm.md)


# Dynavax Tech (DVAX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.2063 | 0.1442 | -0.7700 | 0.0433 | 0.1219 |
| ROE | 20.95% | 14.61% | -68.17% | 4.41% | 10.63% |
| Revenue | 94.88M | 95.44M | 68.16M | 72.03M | 80.63M |
| Net income | 26.93M | 18.72M | -96.10M | 7.05M | 17.59M |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 946.51M | 918.45M | 945.93M | 986.26M | 1.06B |
| Leverage | 1.77 | 1.86 | 1.78 | 1.65 | 1.56 |
| BVPS | 4.55 | 4.22 | 4.29 | 4.76 | 5.19 |
| Turnover | 0.3291 | 0.3269 | 0.3049 | 0.2796 | 0.2563 |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 33.83M | 23.43M | -19.64M | 53.01M | 19.47M |
| Investing CF | 27.32M | 94.79M | 6.91M | 23.37M | -15.46M |
| Financing CF | -61000.00 | -71.92M | -31.88M | -98.88M | 2.48M |
| Free CF | 20.91M | 15.58M | -31.51M | 50.50M | 12.72M |